Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000806

CHIEF EXECUTIVE OFFICER gave up 10,467 shares (to pay taxes)

  • CHIEF EXECUTIVE OFFICER acquired 35,599 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ward Robert · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-26 Exercise or conversion : show line 1 in the form +35,599 156,288 D
2019-06-26 Shares withheld for taxes : show line 2 in the form −10,467 $9.03 $94,517 145,821 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-26 Exercise or conversion : show line 3 in the form Restricted Stock Units −35,599 355,992 D
Loading xslF345X03/form4-06272019_020637.xml…